Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 3/20 | 0.40 |
| ▸ | SELP | P16109 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21391551 | 1.00 | PYGB (0.40) | PYGBSELPCYP1A2GAACA12 | |
| SCHEMBL21391520 | 1.00 | PYGB (0.40) | PYGBSELPCYP1A2GAACA12 | |
| SCHEMBL22906178 | 1.00 | PYGB (0.40) | PYGBSELPCYP1A2GAACA12 | |
| SCHEMBL21391533 | 0.89 | LGALS3 (0.47) | — | |
| SCHEMBL20161572 | 0.84 | PYGB (0.45) | PYGBSELPGAACA12CA1 | |
| SCHEMBL20161941 | 0.84 | PYGB (0.45) | PYGBSELPGAACA12CA1 | |
| SCHEMBL22906104 | 0.82 | LGALS8 (0.37) | — | |
| SCHEMBL2302510 | 0.81 | PYGB (0.48) | PYGBGAACA12CA1CA2 | |
| SCHEMBL2507136 | 0.81 | PYGB (0.48) | PYGBGAACA12CA1CA2 | |
| SCHEMBL12198733 | 0.81 | PYGB (0.48) | PYGBGAACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210017211-A1 | OLIGOSACCHARIDE C-GLYCOSIDE DERIVATIVES | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017211-A1 | OLIGOSACCHARIDE C-GLYCOSIDE DERIVATIVES | OSTC, FUT6, FUT5 | PYGB 1014/4885SELP 274/4885CYP1A2 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.